Table 2.
Comparison of interferon (IFN) scores for patients with primary Sjögren's syndrome with or without different Sjögren's Syndrome Disease Activity Index (ESSDAI) features
| ESSDAI feature | Present | Absent | p Value | ||
|---|---|---|---|---|---|
| Patients (n) | Median (IQR) | Patients (n) | Median (IQR) | ||
| Constitutional | 6 | 6.28 (−1.74, 14.92) | 32 | 5.19 (0.10, 13.97) | NS |
| Lymphadenopathy | – | 38 | 5.19 (−0.26, 14.43) | ND | |
| Glandular | 9 | 14.7 (4.10, 16.22) | 29 | 2.65 (−1.16, 12.41) | 0.029 |
| Articular | 16 | 8.73 (1.02, 14.94) | 22 | 3.53 (−2.02,13.33) | NS |
| Cutaneous | 6 | 15.26 (11.85, 15.90) | 32 | 3.53 (−2.02, 13.33) | <0.001 |
| Pulmonary | – | – | 38 | 5.19 (−0.26–14.43) | ND |
| Renal | – | – | 38 | 5.19 (−0.26–14.43) | ND |
| Muscular | – | – | 38 | 5.19 (−0.26–14.43) | ND |
| PNS | 3 | 15.20 (−5.27–15.58) | 35 | 4.40 (−0.16, 12.87) | NS |
| CNS | – | – | 38 | 5.19 (−0.26–14.43) | ND |
| Haematological | 2 | 16.09 (15.32, 16.85) | 36 | 4.40 (−0.46,12.83) | <0.001 |
| Biological | 20 | 10.21 (1.80, 14.94) | 18 | 3.97 (−3.21, 12.88) | NS |
CNS, central nervous system; PNS, peripheral nerous system; NS, nonsignificant; ND, not determined.